BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15191312)

  • 1. Dose perturbation induced by radiographic contrast inside brachytherapy balloon applicators.
    Kirk MC; Hsi WC; Chu JC; Niu H; Hu Z; Bernard D; Dickler A; Nguyen C
    Med Phys; 2004 May; 31(5):1219-24. PubMed ID: 15191312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study.
    Cheng CW; Mitra R; Li XA; Das IJ
    Med Phys; 2005 Jul; 32(7):2279-87. PubMed ID: 16121583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast effects on dosimetry of a partial breast irradiation system.
    Kassas B; Mourtada F; Horton JL; Lane RG
    Med Phys; 2004 Jul; 31(7):1976-9. PubMed ID: 15305449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the use of HDR 60Co source with the MammoSite radiation therapy system.
    Baltas D; Lymperopoulou G; Zamboglou N
    Med Phys; 2008 Dec; 35(12):5263-8. PubMed ID: 19175085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional quantitative dose reduction analysis in MammoSite balloon by Monte Carlo calculations.
    Zhang Z; Parsai EI; Feldmeier JJ
    J Appl Clin Med Phys; 2007 Nov; 8(4):139-151. PubMed ID: 18449153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose reduction study in vaginal balloon packing filled with contrast for HDR brachytherapy treatment.
    Saini AS; Zhang GG; Finkelstein SE; Biagioli MC
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1263-7. PubMed ID: 20950949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
    Mille MM; Xu XG; Rivard MJ
    Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose perturbations due to contrast medium and air in MammoSite
    Cheng CW; Mitra R; Allen Li X; Das IJ
    Med Phys; 2005 Jul; 32(7Part1):2279-2287. PubMed ID: 28493571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy.
    Oh S; Scott J; Shin DH; Suh TS; Kim S
    Med Phys; 2009 Sep; 36(9):3945-54. PubMed ID: 19810467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of source position uncertainties & balloon deformation in MammoSite brachytherapy on treatment effectiveness.
    Bensaleh S; Bezak E
    Australas Phys Eng Sci Med; 2010 Mar; 33(1):35-44. PubMed ID: 20300986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric optimization of a conical breast brachytherapy applicator for improved skin dose sparing.
    Yang Y; Rivard MJ
    Med Phys; 2010 Nov; 37(11):5665-71. PubMed ID: 21158278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric perturbations due to an implanted cardiac pacemaker in MammoSite(®) treatment.
    Sung W; Kim S; Kim JI; Lee JG; Shin YJ; Jung JY; Ye SJ
    Med Phys; 2012 Oct; 39(10):6185-91. PubMed ID: 23039656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of uncertainties associated with MammoSite brachytherapy on the dose distribution in the breast.
    Bensaleh S; Bezak E
    J Appl Clin Med Phys; 2011 Nov; 12(4):3464. PubMed ID: 22089003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator.
    Hepel JT; Hiatt JR; Cardarelli GA; Wazer DE
    Brachytherapy; 2010; 9(1):81-5. PubMed ID: 19850533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction factors for ionization chamber measurements with the 'Valencia' and 'large field Valencia' brachytherapy applicators.
    Gimenez-Alventosa V; Gimenez V; Ballester F; Vijande J; Andreo P
    Phys Med Biol; 2018 Jun; 63(12):125004. PubMed ID: 29726409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry study of Re-188 liquid balloon for intravascular brachytherapy using polymer gel dosimeters and laser-beam optical CT scanner.
    Wuu CS; Schiff P; Maryanski MJ; Liu T; Borzillary S; Weinberger J
    Med Phys; 2003 Feb; 30(2):132-7. PubMed ID: 12607830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.